Moonwalk Biosciences
Rigel Kishton is currently the Head of Immunology Research at Moonwalk Biosciences. Prior to this, Kishton held the position of Senior Director, Cell and Gene Therapy at Synthego Corporation and Lyell Immunopharma. With a background as a Cancer Research Training Award Fellow at the National Cancer Institute and a Graduate Student at Duke University, Kishton has expertise in identifying tumor-intrinsic genetic defenses against T cell engagement and balancing T cell metabolism in promoting tumor cell survival. Kishton's work focuses on developing strategies for cancer immunotherapy and improving anti-tumor efficacy through genetic modulation of T cell characteristics.
This person is not in any teams
Moonwalk Biosciences
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.